VITRUVIA MEDICAL NA SF1/ CH0461931419 /
| 10/11/2024 8:13:38 AM | Chg. 0.000 | Volume | Bid10/11/2024 | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.400EUR | 0.00% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 587,724.8000EUR | - | - |
Fundamentals
| FY 2020 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -1.05 EUR | - |
| EPS Diluted: | -1.05 EUR | - |
| Revenues per Share: | 3.95 EUR | - |
| Book Value per Share: | 2.65 EUR | - |
| Cash Flow per Share: | -0.14 EUR | - |
| Dividend per Share: | - EUR | - |
| Total | in mill. | |
| Revenues: | 5.80 EUR | - |
| Net Income: | -1.50 EUR | - |
| Operating Cash Flow: | -0.20 EUR | - |
| Cash and Cash Equivalents: | 0.70 EUR | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 0.10 | - |
| P/BV ratio: | 0.15 | - |
| P/CF Ratio: | -2.94 | - |
| PEG: | - | - |
| Earnings Yield: | -262.85% | - |
| Dividend Yield: | - | - |
| Market Capitalization | ||
| Market Capitalization: | 587,724.8000 EUR | 0.0000 EUR |
| Free Float Market Cap.: | - EUR | - EUR |
| Market Cap. / Employee: | - EUR | - EUR |
| Shares Outstanding: | 1.47 mill. | |
Profitability
| Gross Profit Margin: | 34.48% |
| EBIT Margin: | -22.41% |
| Net Profit Margin: | -25.86% |
| Return on Equity: | -38.46% |
| Return on Assets: | -18.99% |
Financial Strength
| Liquidity I / Cash Ratio: | 21.88% |
| Liquidity II / Quick Ratio: | 50.00% |
| Liquidity III / Current Ratio: | 59.38% |
| Debt / Equity Ratio: | 102.56% |
| Dynam. Debt / Equity Ratio: | -2,000.00% |
Efficiency
| Employees: | - |
| Personal Expenses / Employee: | - EUR |
| Revenues / Employee: | - EUR |
| Net Income / Employee: | - EUR |
| Total Assets / Employee: | - EUR |
| * Fiscal Year End: | 12/31/2020 |
| Accounting Standard: | - |
| Currency: | EUR |
